Home
Conditions
Tauopathies

Clinical trial condition

Tauopathies

Explore clinical trials studying Tauopathies. Study availability and eligibility vary by location and protocol.

3,029 public trials 538 recruiting studies

Refine in advanced search Browse all conditions

Tauopathies trial results

Completed

A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab

NCT01723826

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: Banner Alzheimer's Institute Phoenix, Arizona, United States

Mayo Clinic Scottsdale, Arizona, United States

Banner Sun Health Research Insitute Sun City, Arizona, United States

Pharmacology Research Inst Encino, California, United States

View all 86 locations

View Trial Details

Completed

A Non-therapeutic Feasibility Study of the Radioligand [11C]-UCB-J for Imaging Synaptic Density

NCT03577262

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +7 more
Locations: VU Medical Center, Dept. Radiology and Nuclear Medicine Amsterdam, Netherlands

QPS Netherlands B.V. Groningen, Netherlands

University Medical Center Groningen, Nuclear Medicine and Molecular Imaging Groningen, Netherlands

View Trial Details

Completed

Caregiver Study Dr. Phillips

NCT03653871

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Dr. Phillips Center for the Performing Arts Orlando, Florida, United States

View Trial Details

Completed

Phase 1 Test-retest Evaluation of [18F]MNI-958 PET

NCT03545789

Conditions: Alzheimer Disease, Basal Ganglia Diseases, Brain Diseases, +19 more
Locations: Invicro New Haven, Connecticut, United States

View Trial Details

Completed

DL-3-n-butylphthalide Treatment in Patients With Mild to Moderate Alzheimer's Disease Already Receiving Donepezil

NCT02711683

Conditions: Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +7 more
Locations: First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China

View Trial Details

Completed

To Investigate the Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Alzheimer's Patients

NCT00956410

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Novartis Investigative Site Bordeaux, France

Novartis Investigative Site Stockholm, Sweden

Novartis Investigative Site Basel, Switzerland

Novartis Investigative Site Southampton, United Kingdom

View Trial Details

Completed

Safety and Tolerability of Repeated Subcutaneous Injections of CAD106 in Mild Alzheimer's Patients.

NCT00733863

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +6 more
Locations: Centre Hospitalier Universitaire Pellegrin Bordeaux, France

Karolinska Universitetssjukhuset Huddinge Stockholm, Sweden

NeuroPsychologieZentrum Basel, Switzerland

Moorgreen Hospital Southampton, United Kingdom

View Trial Details

Completed

Conversations as a Means to Delay the Onset of Alzheimer's Disease

NCT01571427

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +10 more
Locations: Oregon Health & Science University Portland, Oregon, United States

View Trial Details

Completed

Augmenting Specialty Eating Disorder Clinical Treatment With a Smartphone Application

NCT02484794

Conditions: Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +11 more
Locations: Nova Scotia Health Authority Halifax, Nova Scotia, Canada

View Trial Details

Completed

Isolated Erythrocyte Membrane Susceptibility to Photo-oxidative Stress in Alzheimer's Disease

NCT01707719

Conditions: Adrenal Gland Diseases, Adrenocortical Hyperfunction, Alzheimer Disease, +10 more
Locations: Policlinico Universitario Campus Bio-Medico Rome, RM, Italy

View Trial Details

Tauopathies

Tauopathies trial results

Related conditions